FDA approves Cobenfy for adults with schizophrenia
by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schiz
Updated on: November 29,2024
0
FDA approves Cobenfy for adults with schizophrenia
by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic agonist, for the treatment of schiz
Updated on:November 29,2024
0